Nucleotide sequence encoding a modulator of NF-kappaB

a technology of nf-kappab and nucleotide sequence, which is applied in the direction of peptide/protein ingredients, peptide sources, instruments, etc., can solve the problems of reducing the resulting kinase activity and antisense nucleic acids interfering with the expression of mrna into protein

Inactive Publication Date: 2003-03-27
INST PASTEUR
View PDF1 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0011] It is a further object of the present invention to provide a method and associated assay system for screening substances such as drugs, agents and the like, potentially effective in either mimicking the activity or fighting against the adverse effects of the modulator of NF-.kappa.B and / or its subunits in mammals.
[0012] It is a still further object of the present invention to provide a method for the treatment of mammals to control the transcriptional activity induced by NF-.kappa.B, so as to alter the adverse consequences of such presence or activity, or where beneficial, to enhance such activity.
[0013] It is a still further object of the present invention to provide a method for the treatment of mammals to control the amount or activity of the transcriptional activity of NF-.kappa.B, so as to treat or avert the adverse consequences of invasive, spontaneous or idiopathic pathological states.

Problems solved by technology

Another important issue unanswered was how discrete activation signals triggered by a variety of known stimulators are integrated to give rise to I.kappa.B kinase activity.
Deletion of the HLH motif leaves the coimmunoprecipitation of the two kinases intact, but strongly reduces the resulting kinase activity.
Therefore, antisense nucleic acids interfere with the expression of mRNA into protein.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleotide sequence encoding a modulator of NF-kappaB
  • Nucleotide sequence encoding a modulator of NF-kappaB
  • Nucleotide sequence encoding a modulator of NF-kappaB

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0195] Materials and Methods

[0196] Cells and transfections. The 70Z / 3 murine pre-B cell line and the NF-.kappa.B unresponsive mutant 1.3E2 were maintained in RPMI medium supplemented with 10% foetal calf serum and 50 .mu.M .beta.-mercaptoethanol. 70Z / 3 and 1.3E2 cells were transiently transfected as described (Courtois et al., 1997). Isolated stable clones were prepared as described (Whiteside et al., 1995). Rat-1 and 5R cells were grown in DMEM supplemented with 10% foetal calf serum and transfected using the calcium phosphate coprecipitation method. For measurement of luciferase activity in transiently transfected Rat-1 or 5R cells, approximately 2.times.10.sup.5 cells were transfected with 0.25 .mu.g of a reporter plasmid, 0.25 .mu.g of EF1-lacZ plasmid and 1 .mu.g of either vector or effector plasmid. Cells were harvested 40 to 45 hours after transfection. The amount of lysate used for luciferase assay was determined on the basis of .beta.-galactosidase activity. The results sho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
Tmaaaaaaaaaa
pHaaaaaaaaaa
Login to view more

Abstract

The present invention relates to nucleotide sequences encoding a modulator of NF-kappaB, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-kappaB-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-kappaB, methods of detecting modulator of NF-kappaB using the antibodies, methods of treatment associated with NF-kappaB activation and to methods of identifying compounds which modulate the activity of the modulator of NF-kappaB.

Description

[0001] 1. Field of the Invention[0002] The present invention relates to nucleotide sequences encoding a modulator of NF-.kappa.B, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-.kappa.B activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1.DISCUSSION OF THE BACKGROUND[0003] The Rel / NF-.kappa.B family of transcription factors plays important roles in immune and stress responses, in inflammation, in apoptosis, and regulates the expression of numerous cellular and viral genes (for recent reviews, see Baldwin, 1996; Verma et al., 1995; May and Ghosh, 1998). The NF-.kappa.B activity is composed of homo- or heterodimers of related proteins that share a conserved DNA-binding and dimerization domain called the Rel Homology Domain. In most cell types, NF-.kappa.B is sequestered in the cytoplasm bound to inhibitory p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/00C07K14/47C07K16/18G01N33/68
CPCG01N2500/04G01N2500/10A61K38/00C07K14/4702C07K16/18G01N33/6872G01N2500/02
Inventor YAMAOKA, SHOJICOURTOIS, GILLESISRAEL, ALAINWEIL, ROBERT
Owner INST PASTEUR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products